Macrophage Therapeutics, Inc. Email Format
Biotechnology ResearchNew Jersey, United States2-10 Employees
Macrophage Therapeutics, Inc. is a biotechnology research company focused on developing targeted anti-inflammatory and immuno-oncology therapeutics. It leverages a CD206 receptor–based delivery platform that guides established therapeutics to specific targets, aiming to reduce off-target toxicity and improve therapeutic efficacy. The platform is described as clinically established and is already used in a radiopharmaceutical approved by U.S. and European regulators. Based in Englewood, New Jersey, the company maintains a small team. In the biotechnology research field, it aims to advance macrophage-targeted delivery of therapeutics for inflammatory and immuno-oncology indications.